PharVision Advisers’s eHealth EHTH Stock Holding History

PharVision Advisers’s Portfolio EHTH Stock Details EHTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,497	Closed	-$131K	–	272
2025 Q4	$131K	Buy	+28,497	New	+$126K	0.07%	634

Other funds holding EHTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

RCM

Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PharVision Advisers's EHTH Position: Q1 2026 in Review

PharVision Advisers sold out of eHealth (EHTH) in Q1 2026, closing a stake of 28,497 shares — an estimated $131K sold.

PharVision Advisers first reported a position in EHTH in Q4 2025 and held it in 1 quarter. The position peaked at $131K in Q4 2025. 104 funds tracked by Wall St. Rank hold EHTH as of Q1 2026.

PharVision Advisers reported no remaining eHealth position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 28,497 eHealth shares in Q1 2026, an estimated $131K.
PharVision Advisers first reported a position in eHealth in Q4 2025 and held it in 1 quarter.
PharVision Advisers's eHealth position peaked at $131K in Q4 2025.
104 funds tracked by Wall St. Rank held eHealth as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.